FindTrial
Sign In

To measure the clinical increase in alveolar ridge width after augmentation with self-prepared FDBA block graft and amnion chorion membrane

To Evaluate the Clinical Outcomes of Horizontal (Lateral) Alveolar Ridge Augmentation Using Indigenously Prepared FDBA Block Graft and Amnion Chorion Membrane. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061104
Enrollment
10
Registered
2024-01-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge

Interventions

Intervention1: Alveolar Ridge Augmentation using FDBA block graft and Amnion-Chorion membrane: Alveolar Ridge Augmentation will be done using Indigenously prepared FDBA block graft secured with titani

Sponsors

Bhawana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with ridge defect with ridge width(RW) less than 4mm which was insufficient for standard implant placement. Presence of maxillary or mandibular single or multiple (maximum 3 teeth loss) horizontal ridge defects. Absence of any sign of pathology at the proposed surgical sites.

Exclusion criteria

Exclusion criteria: Native Bone with any sign of pathology such as inflammation, or pus discharge. Subjects with bone disease (Paget’s disease, rickets, osteoporosis, arthritis, multiple myeloma etc.) and Radiographic evidence of bone tumour (benign ormalignant) or any cyst. Uncontrolled systemic diseases (uncontrolled diabetes, uncontrolled hypertension), taking immunosuppressive anticoagulant medications and pregnancy. Subjects under longterm bisphosphonate therapy. smokers

Design outcomes

Primary

MeasureTime frame
•To evaluate the change in horizontal alveolar ridge width using FDBA block graft with Amnion-chorion membrane in deficient alveolar ridges. Timepoint: baseline and after 6 months—

Secondary

MeasureTime frame
To evaluate the clinical adverse effects of FDBA block graft and ACM, if any.Timepoint: baseline and after 6 months—

Countries

India

Contacts

Public Contactbhawana oriya

Maulana Azad Institute of Dental Sciences

arundeep.kaur.lamba@gmail.com9654700980

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026